88 related articles for article (PubMed ID: 1978946)
1. The effect of somatostatin on 5-hydroxytryptamine release from a carcinoid tumor.
Lawrence JP; Ishizuka J; Haber B; Townsend CM; Thompson JC
Surgery; 1990 Dec; 108(6):1131-4; discussion 1134-5. PubMed ID: 1978946
[TBL] [Abstract][Full Text] [Related]
2. The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells.
Wängberg B; Nilsson O; Theodorsson E; Dahlström A; Ahlman H
Br J Cancer; 1991 Jul; 64(1):23-8. PubMed ID: 1713051
[TBL] [Abstract][Full Text] [Related]
3. Histamine release from a gastric carcinoid: provocation by pentagastrin and inhibition by somatostatin.
Roberts LJ; Bloomgarden ZT; Marney SR; Rabin D; Oates JA
Gastroenterology; 1983 Feb; 84(2):272-5. PubMed ID: 6184258
[TBL] [Abstract][Full Text] [Related]
4. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
Ishizuka J; Beauchamp RD; Sato K; Townsend CM; Thompson JC
J Cell Physiol; 1993 Jul; 156(1):112-8. PubMed ID: 8391003
[TBL] [Abstract][Full Text] [Related]
5. On the mode of action of the pentagastrin test in the carcinoid syndrome.
Grönstad KO; Nilsson O; Hedman I; Skolnik G; Dahlström A; Ahlman H
Scand J Gastroenterol; 1985 May; 20(4):508-11. PubMed ID: 4023617
[TBL] [Abstract][Full Text] [Related]
6. The effect of beta andrenoceptor stimulation of canine stomach on pentagastrin-stimulated histamine release.
Payne NA; Gerber JG
J Pharmacol Exp Ther; 1996 Mar; 276(3):984-8. PubMed ID: 8786579
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine insights from the laboratory to the clinic.
Ahlman H; Nilsson O; Wängberg B; Dahlström A
Am J Surg; 1996 Jul; 172(1):61-7. PubMed ID: 8686805
[TBL] [Abstract][Full Text] [Related]
8. Unexpected growth-stimulatory effect of somatostatin analogue on cultured human pancreatic carcinoid cells.
Ishizuka J; Beauchamp RD; Evers BM; Townsend CM; Thompson JC
Biochem Biophys Res Commun; 1992 Jun; 185(2):577-81. PubMed ID: 1351720
[TBL] [Abstract][Full Text] [Related]
9. SMS 201-995 and provocation tests in preparation of patients with carcinoids for surgery or hepatic arterial embolization.
Ahlman H; Ahlund L; Dahlström A; Martner J; Stenqvist O; Tylén U
Anesth Analg; 1988 Dec; 67(12):1142-8. PubMed ID: 2461665
[TBL] [Abstract][Full Text] [Related]
10. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Weckbecker G; Raulf F; Bodmer D; Bruns C
Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
[TBL] [Abstract][Full Text] [Related]
11. Octreotide inhibition of serotonin-induced ileal chloride secretion.
Hurst RD; Ballantyne GH; Modlin IM
J Surg Res; 1995 Dec; 59(6):631-5. PubMed ID: 8538158
[TBL] [Abstract][Full Text] [Related]
12. The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man.
Whitehouse I; Beglinger C; Fried M; Gyr K
Hepatogastroenterology; 1984 Oct; 31(5):227-9. PubMed ID: 6150888
[TBL] [Abstract][Full Text] [Related]
13. The effect of somatostatin analogue SMS 201-995 on serotonin levels in the medium of primary carcinoid cell cultures.
Jacobsen MB; Hanssen LE; Bratlie J
Scand J Gastroenterol; 1992 Dec; 27(12):1077-83. PubMed ID: 1475626
[TBL] [Abstract][Full Text] [Related]
14. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
[TBL] [Abstract][Full Text] [Related]
15. Secretin inhibits canine gastric acid secretion in response to pentagastrin by modulating gastric histamine release.
Gerber JG; Payne NA
J Pharmacol Exp Ther; 1996 Nov; 279(2):718-23. PubMed ID: 8930176
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion.
Parekh D; Ishizuka J; Townsend CM; Haber B; Beauchamp RD; Karp G; Kim SW; Rajaraman S; Greeley G; Thompson JC
Pancreas; 1994 Jan; 9(1):83-90. PubMed ID: 8108375
[TBL] [Abstract][Full Text] [Related]
17. Carcinoid syndrome.
Zambrzycki JK; Elliott CG
Nurse Anesth; 1993 Dec; 4(4):198-201. PubMed ID: 7907889
[TBL] [Abstract][Full Text] [Related]
18. Adrenergic control of serotonin release from a midgut carcinoid tumour.
Nilsson O; Grönstad KO; Goldstein M; Skolnik G; Dahlström A; Ahlman H
Int J Cancer; 1985 Sep; 36(3):307-12. PubMed ID: 2411674
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of somatostatin's inhibition of hormone release: participation of voltage-gated calcium channels and G-proteins.
Scherübl H; Hescheler J; Riecken EO
Horm Metab Res Suppl; 1993; 27():1-4. PubMed ID: 8101178
[TBL] [Abstract][Full Text] [Related]
20. The release of 3H-1-methyl-4-phenylpyridinium from bovine adrenal chromaffin cells is modulated by somatostatin.
Ribeiro L; Martel F; Azevedo I
Regul Pept; 2006 Dec; 137(3):107-13. PubMed ID: 16846655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
